Trials / Unknown
UnknownNCT04581746
Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)
Evaluation of the Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,800 (estimated)
- Sponsor
- Tourcoing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The non-essential and non-urgent follow-up consultations of patients living with HIV were postponed or transformed into "teleconsultation" or exchanges of e-mails between practitioners and patients during COVID-19 epidemic. This change in care can have an impact on follow-up and access to treatment for PVVIH.
Detailed description
On 16 March 2020, an instruction to postpone "non-urgent" consultations was given to doctors. Thus, the non-essential and non-urgent follow-up consultations of patients living with HIV were postponed or transformed into "teleconsultation" or exchanges of e-mails between practitioners and patients. This change in care can have an impact on follow-up and access to treatment for PVVIH. In addition, the epidemic itself may have consequences: PVVIH may be at greater risk because of their immunosuppression and associated co-morbidities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire | bi-monthly questionnaire and then one visit with questionnaire and covid-19 test |
Timeline
- Start date
- 2020-11-25
- Primary completion
- 2022-06-01
- Completion
- 2022-12-01
- First posted
- 2020-10-09
- Last updated
- 2022-05-10
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04581746. Inclusion in this directory is not an endorsement.